US 8507195
MiRNAs dysregulated in triple-negative breast cancer
granted A61PA61P35/00
Quick answer
US patent 8507195 (MiRNAs dysregulated in triple-negative breast cancer) held by The Regents of the University of Colorado expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P35/00